Apogee Therapeutics (APGE) Enterprise Value (2022 - 2026)
Apogee Therapeutics (APGE) reported Enterprise Value of -$1.1 billion for Q1 2026, down 106.48% year-over-year from $16.4 billion in Q1 2025, and down 45.15% on a QoQ basis from -$730.2 million in Q4 2025.
Apogee Therapeutics (APGE) has 5 years of Enterprise Value data on file, last reported at -$1.1 billion in Q1 2026.
- Quarterly Enterprise Value fell 106.48% year-over-year to -$1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.1 billion (down 106.48% YoY) and the FY2025 annual result came in at -$730.2 million, down 40.25% from the prior year.
- Enterprise Value retreated to -$1.1 billion in Q1 2026 per APGE's latest filing, from -$730.2 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$5.0 million in Q2 2022 and bottomed at -$1.1 billion in Q1 2026.
- The 5-year median for Enterprise Value is -$517.0 million (2024), against an average of -$498.2 million.
- The widest annual swing landed in 2023, when Enterprise Value slumped 2415.08%; it then soared 37.11% in 2025.
- Tracing APGE's Enterprise Value over 5 years: stood at -$151.9 million in 2022, then slumped by 160.36% to -$395.5 million in 2023, then slumped by 31.66% to -$520.7 million in 2024, then tumbled by 40.25% to -$730.2 million in 2025, then plunged by 45.15% to -$1.1 billion in 2026.
- Per Business Quant, the three latest APGE Enterprise Value figures stand at -$1.1 billion (Q1 2026), -$730.2 million (Q4 2025), and -$527.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Apogee Therapeutics | 5.53 Bn | 4.47 Bn | - | -1.06 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.06 Bn |
| Dec 31, 2025 | -730.19 Mn |
| Sep 30, 2025 | -527.29 Mn |
| Jun 30, 2025 | -505.39 Mn |
| Mar 31, 2025 | -513.33 Mn |
| Dec 31, 2024 | -520.65 Mn |
| Sep 30, 2024 | -526.05 Mn |
| Jun 30, 2024 | -676.20 Mn |
| Mar 31, 2024 | -816.20 Mn |
| Dec 31, 2023 | -395.46 Mn |
| Sep 30, 2023 | -422.87 Mn |
| Jun 30, 2023 | -125.10 Mn |
| Dec 31, 2022 | -151.89 Mn |
| Jun 30, 2022 | -4.97 Mn |